Multiple sclerosis; a disease of reproductive-aged women and the dilemma involving contraceptive methods

被引:0
|
作者
Turkyilmaz, Esengul [1 ]
Yildirim, Melahat [1 ]
Avsar, Ayse Filiz Yavuz [2 ]
机构
[1] Ataturk Training & Res Hosp, Dept Obstet & Gynecol, Ankara, Turkey
[2] Yildirim Beyazit Univ, Dept Obstet & Gynecol, Ankara, Turkey
关键词
Multiple Sclerosis; contraception; contraceptives;
D O I
10.5152/jtgga.2015.15186
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Multiple sclerosis (MS) is an autoimmune disorder characterized by chronic inflammation in the central nerves system. Because the disease predominantly affects women of reproductive ages, having knowledge about contraception options for MS patients can make clinicians provide better counseling. Although most contraceptive methods are generally accepted as safe and effective in MS patients, recent studies have raised questions about their potential adverse effects on the disease. The use of contraceptive methods to avoid unintended pregnancies is crucial in MS patients, particularly during the relapse phase of the disease or the time when the disease is not completely under control. This review investigates the contraception options and their effects on female MS patients. Providing appropriate contraception options to multiple sclerosis patients will be one of the most challenging issues for clinicians to deal with. Recent studies have raised questions that the use of hormonal contraceptives may at least partly contribute to the rise in incidence of MS in women. This review investigates the contraception options and their effects on female MS patients.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 50 条
  • [1] The Contraceptive Needs of Older Reproductive-Aged Women
    Black, Amanda
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (12): : 1361 - 1361
  • [2] Contraceptive use and the role of contraceptive counseling in reproductive-aged women with cancer
    Maslow, Bat-Sheva L.
    Morse, Christopher B.
    Schanne, Allison
    Loren, Alison
    Domchek, Susan M.
    Gracia, Clarisa R.
    CONTRACEPTION, 2014, 90 (01) : 79 - 85
  • [3] Exploration of modern contraceptive methods using patterns among later reproductive-aged women in Bangladesh
    Rana, Md. Shohel
    Khanam, Shimlin Jahan
    Alam, Md. Badsha
    Hassen, Md. Tahir
    Kabir, Md. Iqbal
    Khan, Md. Nuruzzaman
    PLOS ONE, 2024, 19 (04):
  • [4] Investigation and analysis of contraceptive measures towards different reproductive-aged women in Yangzhou
    He, X. Y.
    Yao, H.
    Ma, Z. N.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2014, 41 (06): : 704 - 708
  • [5] Exposure to multiple chemicals in a cohort of reproductive-aged Danish women
    Rosofsky, Anna
    Janulewicz, Patricia
    Thayer, Kristina A.
    McClean, Michael
    Wise, Lauren A.
    Calafat, Antonia M.
    Mikkelsen, Ellen M.
    Taylor, Kyla W.
    Hatch, Elizabeth E.
    ENVIRONMENTAL RESEARCH, 2017, 154 : 73 - 85
  • [6] CONTRACEPTIVE COUNSELING FOR REPRODUCTIVE-AGED WOMEN TREATED AT STANFORD CANCER INSTITUTE: A RETROSPECTIVE ANALYSIS
    Johansen, S.
    Lerma, K.
    Henry, S.
    Tamaresis, J.
    Wood, D.
    Shaw, K.
    CONTRACEPTION, 2016, 94 (04) : 413 - 413
  • [7] Screening for Obesity in Reproductive-Aged Women
    Zera, Chloe
    McGirr, Susan
    Oken, Emily
    PREVENTING CHRONIC DISEASE, 2011, 8 (06):
  • [8] Contraindications to progestin-only oral contraceptive pills among reproductive-aged women
    White, Kari
    Potter, Joseph E.
    Hopkins, Kristine
    Fernandez, Leticia
    Amastae, Jon
    Grossman, Daniel
    CONTRACEPTION, 2012, 86 (03) : 199 - 203
  • [9] Trends in the use of disease-modifying therapies among reproductive-aged women with multiple sclerosis in the United States from 2010 to 2019
    Duchesneau, Emilie D.
    Kinlaw, Alan C.
    Jonsson Funk, Michele
    Pate, Virginia
    Lund, Jennifer L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (04) : 481 - 487
  • [10] Trends in the use of disease-modifying therapies among reproductive-aged women with multiple sclerosis in the United States 2001-2017
    Duchesneau, Emilie D.
    Funk, Michele Jonsson
    Kinlaw, Alan C.
    Lund, Jennifer L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 239 - 239